On Monday, Virgin America Inc (NASDAQ:VA)’s shares declined -2.59% to $29.76.
Virgin America Inc (VA) will declare its First Quarter 2015 Financial Results on Thursday, April 30, 2015. The Company will hold a live webcast to talk about the results, details as follows:
Virgin America Inc. provides planned air travel services. As of December 31, 2014, it offered services to 21 airports in the United States and Mexico with a fleet of about 53 Airbus single-aisle aircraft, counting of 10 Airbus A319s and 43 Airbus A320s.
Mylan NV (NASDAQ:MYL)’s shares dropped -2.54% to $68.04.
Mylan NV (MYL) commented on recent media speculation.
Mylan Executive Chairman Robert J. Coury commented, “We note that there has been some media speculation with regard to a potential bid for Mylan by Teva and that this rumor has been circulating for some time. Although it has been company policy not to comment on such media speculation, given current circumstances, we believe it is appropriate to do so now.
Mylan is fully committed to its stand-alone strategy, counting its proposal to attain Perrigo, and recently’s speculation has no influence whatsoever on this strategy.
Mylan N.V., through its auxiliaries, develops, licenses, manufactures, markets, and distributes generic, branded generic, and specialty pharmaceuticals worldwide. The company provides generic or branded generic pharmaceutical products in tablet, capsule, injectable, or transdermal patch forms, in addition to active pharmaceutical ingredients (APIs).
At the end of Monday’s trade, Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA)‘s shares dipped -2.50% to $63.29.
Teva Pharmaceutical Industries Ltd (ADR) (TEVA) declared recently that it will release its first quarter 2015 financial results on Thursday, April 30, 2015 at 7:00 a.m. ET.
Teva will host a conference call and live webcast on the same day, at 8:00 a.m. ET to talk about its first quarter 2015 results and overall business environment. A Question & Answer session will follow this talk about.
Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic, specialty, and other pharmaceutical products worldwide. The company operates in two segments, Generic Medicines and Specialty Medicines. The Generic Medicines segment offers generic or branded generic medicines; specialized products, such as sterile products, hormones, narcotics, high-potency drugs, and cytotoxic substances; and active pharmaceutical ingredients.
Sprint Corp (NYSE:S), ended its Monday’s trading session with -2.35% loss, and closed at $4.99.
Tracy Elizabeth Nolan has been named president and general manager for Sprint Corp (S) in Illinois and Wisconsin. This is a newly created position that will enable Sprint to devote more resources and focus to key cities in the Midwest, counting Chicago and Milwaukee.
Nolan will have responsibilities for sales strategy, network oversight, customer service, marketing communications and general operations in Illinois and Wisconsin. With Nolan’s appointment as the company’s first local area president, the company will develop market-specific offerings to reflect the unique needs of customers across the consumer and business segments in Illinois and Wisconsin.
Sprint Corporation provides wireless and wireline communications services to consumers, businesses, and government users in the United States, Puerto Rico, and the U.S. Virgin Islands.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
